Verona Pharma Enters $650MM Strategic Financing Agreements with Oaktree and OMERS
Verona Pharma and its wholly-owned subsidiary entered into strategic financing agreements providing access to up to $650 million from funds managed by Oaktree Capital Management and OMERS Life Sciences.